AORTArtivion, Inc.

AORT Stock Price, Valuation & Chart | Artivion, Inc.

Compare

$26.340-0.75 (-2.77%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices AORT intrinsic value AORT calculated fair value vs price

Overview Financials Dividends Ratios

AORT Historical price chart

AORT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.28B

PE Ratio43.9

EPS0.6

Trading Volume549.49K

Today's High/Low27.92/26.29

Dividend Yield0.00

52 Week High/Low48.25/19.16

Shares Outstanding48.54M

AORT Financial Statement

AORT Analyst ratings

AORT Analysis & performance metrics

AORT Company profile

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine…

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita…

AORT Management team

Name

Position

Lance A. Berry CPACFO

EVice President, Chief Operating Officer, Chief Financial Officer & Treasurer

Marshall S. Stanton M.D.

Senior Vice President of Clinical Research & Chief Medical Officer

James Patrick MackinCEO

Chairman, President & Chief Executive Officer

John E. Davis

Senior Vice President & Chief Commercial Officer

Amy D. Horton CPA

Vice President & Chief Accounting Officer

Jason D. Asper

Senior Vice President and Chief Strategy & Digital Officer

Matthew A. Getz

Vice President of Human Resources & Chief Human Resources Officer

Jean F. Holloway Esq.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Name

Position

Lance A. Berry CPACFO

EVice President, Chief Operating Officer, Chief Financial Officer & Treasurer

Marshall S. Stanton M.D.

Senior Vice President of Clinical Research & Chief Medical Officer

James Patrick MackinCEO

Chairman, President & Chief Executive Officer

John E. Davis

Senior Vice President & Chief Commercial Officer

Amy D. Horton CPA

Vice President & Chief Accounting Officer

Jason D. Asper

Senior Vice President and Chief Strategy & Digital Officer

Matthew A. Getz

Vice President of Human Resources & Chief Human Resources Officer

Jean F. Holloway Esq.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Management Team

Lance A. Berry CPACFO

EVice President, Chief Operating Officer, Chief Financial Officer & Treasurer

Marshall S. Stanton M.D.

Senior Vice President of Clinical Research & Chief Medical Officer

James Patrick MackinCEO

Chairman, President & Chief Executive Officer

John E. Davis

Senior Vice President & Chief Commercial Officer

Amy D. Horton CPA

Vice President & Chief Accounting Officer

Jason D. Asper

Senior Vice President and Chief Strategy & Digital Officer

Matthew A. Getz

Vice President of Human Resources & Chief Human Resources Officer

Jean F. Holloway Esq.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Management

Lance A. Berry CPACFO

EVice President, Chief Operating Officer, Chief Financial Officer & Treasurer

Marshall S. Stanton M.D.

Senior Vice President of Clinical Research & Chief Medical Officer

James Patrick MackinCEO

Chairman, President & Chief Executive Officer

John E. Davis

Senior Vice President & Chief Commercial Officer

Amy D. Horton CPA

Vice President & Chief Accounting Officer

Jason D. Asper

Senior Vice President and Chief Strategy & Digital Officer

Matthew A. Getz

Vice President of Human Resources & Chief Human Resources Officer

Jean F. Holloway Esq.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Total 8 executives

AORT Frequently asked questions

What is Artivion, Inc. (AORT) Stock Price?

Current stock price of Artivion, Inc. (AORT) stock is $26.340. The stock price is -2.77% lower in the session. The intraday range can be seen from this page. Volume of Artivion, Inc. (AORT) stock is 549.49K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Artivion, Inc. (AORT) stock price going up or down today?

The stock price of Artivion, Inc. (AORT) can change with earnings, company news, and overall market sentiment. Artivion, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Artivion, Inc. stock expensive at its current price?

Whether Artivion, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AORT on this page is 43.90. EPS on this page is 0.60. Compare those figures with peers and growth expectations before deciding if the current Artivion, Inc. price is justified.

How has the stock price of Artivion, Inc. (AORT) performed historically?

Historical performance for Artivion, Inc. (AORT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AORT reacted to past earnings and market events.

Should I buy Artivion, Inc. (AORT) stock, at this price?

Buying Artivion, Inc. (AORT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.